Head-to-head · Value Score
bmiMD vs Freya Meds
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Freya Meds a 64. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameFreya Meds
#321 · Grade C · Watch List
Est. first month
From $250/mo (quarterly plan, compounded)
Save ~81% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 64 — an est. $99/mo first month, with no teaser step-up baked in. Freya Meds isn't out of it: Patients wanting dietitian-supported compounded GLP-1 programs.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Freya Meds |
|---|---|---|
| Value Score | 89 (A) | 64 (C) |
| Est. first month | $99/mo | From $250/mo (quarterly plan, compounded) |
| Save vs brand-name | ~93% | ~81% |
| Semaglutide | $99/mo | From $250/mo (quarterly plan, compounded) |
| Tirzepatide | $139/mo | From $332/mo (quarterly plan, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Freya Meds
Freya Meds is a GLP-1 specialist offering compounded semaglutide ($250–$297/mo) and compounded tirzepatide ($332–$390/mo).
Why it's a deal
- GLP-1 specialist — not a multi-category telehealth
- Price includes unlimited doctor consultations, monthly group calls, and a dietitian consultation
- Both semaglutide and tirzepatide available
- Multi-month discount on quarterly billing
- Claims 450,000+ enrolled
The fine print
- No visible LegitScript or PCAB accreditation
- Above-average pricing ($250–$390/mo)
- Compounded only — no brand-name options
- Now serves 49 U.S. states (one state excluded; specific exclusion not named)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Freya Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.